Patent details
300451 Product Name: Eltrombopag, desgewenst in de vorm van een farmaceutisch aanvaardbaar zout of solvaat (met inbegrip van een hydraat), in het bijzonder eltrombopag olamine.
The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents
Basic Information
- Publication number:
- 300451
- Type:
- Certificate
- SPC Type:
- Medical
- Basic Patent Number:
- EP1294378
- Status:
- Expired Art. 14 (a) of the EC Regulations
- Application number:
- 300451
- Procedural language:
- Dutch
- First Applicant Residence Country:
Paediatric Extension
- SPC Extension Filing Date:
- 08/10/2019
- SPC Extension Agent/Owner Name:
- Novartis AG , ir. F.A. Geurts c.s.
- SPC Extension Status:
- Extension Granted
- SPC Extension Grant Date:
- 09/01/2020
- SPC Extension Request Refusal Date:
- SPC Extension Revocation Date:
Marketing Authorization
- Marketing Authorization Number:
- EU/1/10/612/001-006
- Marketing Authorization Type:
- EEA
- Marketing Authorization Date:
- 15/03/2010
- Marketing Authorization Country:
- European Union (EU)
Dates
- Filing date:
- 14/05/2010
- First Marketing Authorization date:
- 15/03/2010
- Grant date:
- 23/06/2010
- Activation date:
- 24/05/2021
- Lapsed By Non Payment Annual Fee Date:
- Renunciation Date:
- NullificationDate:
- Registration date:
- 14/05/2010
- SPC/SPC Extension Expiration Date:
- 14/09/2025
- Lapsed By Expiration Date:
- 15/09/2025
- Withdrawal date:
- Revocation Date:
- Invalidity Date:
- Withdrawal Market Authorization Date:
- Refusal Date:
Applicant/holder
- From:
- 01/07/2016
- Name:
- Novartis AG
- Address:
- Lichtstrasse 35, 4056, Basel, Switzerland (CH)
Historical Applicant/holder
- From:
- 01/07/2016
- To:
- 01/07/2016
- Name:
- Glaxo Group Limited
- Address:
- 980 Great West Road, TW8 9GS, Brentford, Middlesex, United Kingdom (GB)
- From:
- 01/07/2016
- To:
- 01/07/2016
- Name:
- Novartis Pharma AG
- Address:
- Lichtstrasse 35, 4056, Basel, Switzerland (CH)
- From:
- 14/05/2010
- To:
- 14/05/2010
- Name:
- SMITHKLINE BEECHAM CORPORATION
- Address:
- One Franklin Plaza P.O. Box 7929, 19103-7929, Philadelphia, Pennsylvania, United States of America (US)
- From:
- 14/05/2010
- To:
- 01/07/2016
- Name:
- GlaxoSmithKline LLC
- Address:
- One Franklin Plaza P.O. Box 7929, 19103-7929, Philadelphia, Pennsylvania, United States of America (US)
Agent
- Name:
- ir. F.A. Geurts c.s.
- From:
- 14/05/2010
- Address:
- Octrooibureau Vriesendorp & Gaade B.V. Koninginnegracht 19, 2514 AB, Den Haag, Netherlands (NL)
- To:
Publication
Bulletin
1
- Bulletin Heading:
- VRV
- Journal edition number:
- 38/25
- Publication date:
- 17/09/2025
- Description:
- Lapse or annulment
2
- Bulletin Heading:
- SPC
- Journal edition number:
- 21/21
- Publication date:
- 26/05/2021
- Description:
- Applications and granted Supplementary Protection Certificates (or the extensions of the Supplementary Protection Certificates)
3
- Bulletin Heading:
- SPC
- Journal edition number:
- 03/20
- Publication date:
- 15/01/2020
- Description:
- Applications and granted Supplementary Protection Certificates (or the extensions of the Supplementary Protection Certificates)
4
- Bulletin Heading:
- SPC
- Journal edition number:
- 42/19
- Publication date:
- 16/10/2019
- Description:
- Applications and granted Supplementary Protection Certificates (or the extensions of the Supplementary Protection Certificates)
5
- Bulletin Heading:
- CO
- Journal edition number:
- 39/16
- Publication date:
- 28/09/2016
- Description:
- Changes in the Netherlands Patent Register
6
- Bulletin Heading:
- CO
- Journal edition number:
- 39/16
- Publication date:
- 28/09/2016
- Description:
- Changes in the Netherlands Patent Register
7
- Bulletin Heading:
- CO
- Journal edition number:
- 39/16
- Publication date:
- 28/09/2016
- Description:
- Changes in the Netherlands Patent Register
8
- Bulletin Heading:
- SPC
- Journal edition number:
- 2010/19
- Publication date:
- 30/06/2010
- Description:
- Applications and granted Supplementary Protection Certificates (or the extensions of the Supplementary Protection Certificates)
9
- Bulletin Heading:
- MED
- Journal edition number:
- 2010/14
- Publication date:
- 26/05/2010
- Description:
- Other communications
10
- Bulletin Heading:
- SPC
- Journal edition number:
- 2010/14
- Publication date:
- 26/05/2010
- Description:
- Applications and granted Supplementary Protection Certificates (or the extensions of the Supplementary Protection Certificates)
Deed
Change of owner(s)
- Change Kind/ Decision Type:
- Assignment
- Deed Number:
- RC201601899B
- Date Registered:
- 01/07/2016
- License Effective Date:
- License Expiration Date:
- Scope of License:
- Deed Filer:
- ir. F.A. Geurts c.s.
- Journal Edition Number:
- Text:
- Deed Status:
- Country Code:
- Updated License Number:
- Terminated License Number:
Added Owner(s)
- Name:
- Glaxo Group Limited
- Address:
- 980 Great West Road, TW8 9GS, Brentford, Middlesex, United Kingdom (GB)
Changed Pledgee
- Name:
- Address:
Removed Usufructuary
- Name:
- Address:
Added Usufructuary
- Name:
- Address:
Changed Usufructuary
- Name:
- Address:
Change of owner(s)
- Change Kind/ Decision Type:
- Assignment
- Deed Number:
- RC201601899C
- Date Registered:
- 01/07/2016
- License Effective Date:
- License Expiration Date:
- Scope of License:
- Deed Filer:
- ir. F.A. Geurts c.s.
- Journal Edition Number:
- Text:
- Deed Status:
- Country Code:
- Updated License Number:
- Terminated License Number:
Added Owner(s)
- Name:
- Novartis Pharma AG
- Address:
- Lichtstrasse 35, 4056, Basel, Switzerland (CH)
Changed Pledgee
- Name:
- Address:
Removed Usufructuary
- Name:
- Address:
Added Usufructuary
- Name:
- Address:
Changed Usufructuary
- Name:
- Address:
Change of owner(s)
- Change Kind/ Decision Type:
- Assignment
- Deed Number:
- RC201601899G
- Date Registered:
- 01/07/2016
- License Effective Date:
- License Expiration Date:
- Scope of License:
- Deed Filer:
- ir. F.A. Geurts c.s.
- Journal Edition Number:
- Text:
- Deed Status:
- Country Code:
- Updated License Number:
- Terminated License Number:
Added Owner(s)
- Name:
- Novartis AG
- Address:
- Forum 1, Novartis Campus, 4056, Basel, Switzerland (CH)
Changed Pledgee
- Name:
- Address:
Removed Usufructuary
- Name:
- Address:
Added Usufructuary
- Name:
- Address:
Changed Usufructuary
- Name:
- Address:
Change of owner(s)
- Change Kind/ Decision Type:
- Change of owner(s) name
- Deed Number:
- 012595-A012595-1
- Date Registered:
- 14/05/2010
- License Effective Date:
- License Expiration Date:
- Scope of License:
- Deed Filer:
- ir. F.A. Geurts c.s.
- Journal Edition Number:
- Text:
- Deed Status:
- Country Code:
- Updated License Number:
- Terminated License Number:
Changed Pledgee
- Name:
- Address:
Removed Usufructuary
- Name:
- Address:
Added Usufructuary
- Name:
- Address:
Changed Usufructuary
- Name:
- Address:
Annual Fee
- Annual Fee(s) Due Date:
- Annual Fee Number:
- Last Annual Payment Date:
- 07/05/2025
- Last Annual Fee Paid Number:
- 25
- Last Annual Fee Paid Amount:
- 2400 Euro
- Payer:
- Arnold & Siedsma BV
| Filing date | Document type | Document Description | Number of pages | File Type | ||
|---|---|---|---|---|---|---|
| 09/01/2020 | Outgoing Correspondence | Decision extension duration | 1 | /1/5/4/0/0/0400300451/docs/300451_4_outgoingcorrespondence20200110092931022.pdf | ||
| 09/01/2020 | SPC Documents | Certificate SPC | 1 | /1/5/4/0/0/0400300451/docs/300451_6_supplprotectioncertificate20200110092931105.pdf | ||
| 17/10/2019 | Outgoing Correspondence | Confirmation receipt request for extension | 1 | /1/5/4/0/0/0400300451/docs/300451_7_303813l505.pdf | ||
| 08/10/2019 | SPC Documents | Annex SPC | 4 | /1/5/4/0/0/0400300451/docs/300451_2_supplprotectioncertificate20200909042352169.pdf | ||
| 08/10/2019 | SPC Documents | Annex SPC | 4 | /1/5/4/0/0/0400300451/docs/300451_3_supplprotectioncertificate20200909043435799.pdf | ||
| 08/10/2019 | Payment Order Dossier | Payment Order | 2 | /1/5/4/0/0/0400300451/docs/300451_5_paymentorderdossier20191010115800277.pdf | ||
| 08/10/2019 | SPC Documents | Annex SPC | 3 | /1/5/4/0/0/0400300451/docs/300451_9_supplprotectioncertificate20200909041745432.pdf | ||
| 08/10/2019 | Application Form | Confirmed application form | 4 | /1/5/4/0/0/0400300451/docs/300451_13_applicationform20191016100229981.pdf | ||
| 08/10/2019 | Incoming Correspondence Paper | Accompanying letter incoming document | 2 | /1/5/4/0/0/0400300451/docs/300451_14_incomingcorrespondencepaper20191016100340442.pdf | ||
| 08/10/2019 | SPC Documents | Certificate SPC | 1 | /1/5/4/0/0/0400300451/docs/300451_16_supplprotectioncertificate20191016100710044.pdf | ||
| 08/10/2019 | SPC Documents | Annex SPC | 2 | /1/5/4/0/0/0400300451/docs/300451_17_supplprotectioncertificate20191016100321010.pdf | ||
| 08/10/2019 | Incoming Correspondence Paper | Accompanying letter incoming document | 1 | /1/5/4/0/0/0400300451/docs/300451_18_incomingcorrespondencepaper20191016100618505.pdf | ||
| 08/10/2019 | SPC Documents | Summary of the characteristics of the product | 80 | /1/5/4/0/0/0400300451/docs/300451_19_supplprotectioncertificate20200909043146852.pdf | ||
| 08/10/2019 | SPC Documents | Annex SPC | 5 | /1/5/4/0/0/0400300451/docs/300451_22_supplprotectioncertificate20200909042159172.pdf | ||
| 28/09/2016 | Outgoing Correspondence | Letter registration deed | 2 | /1/5/4/0/0/0400300451/docs/300451_27_86692l118.pdf | ||
| 01/07/2016 | Incoming Correspondence Paper | Accompanying letter incoming document | 2 | /1/5/4/0/0/0400300451/docs/300451_0_incomingcorrespondencepaper20160831092630978.pdf | ||
| 01/07/2016 | Request for Change | First filed deed | 3 | /1/5/4/0/0/0400300451/docs/300451_15_rfc20160927015124796.pdf | ||
| 01/07/2016 | Request for Change | First filed deed | 12 | /1/5/4/0/0/0400300451/docs/300451_28_rfc20160831092631080.pdf | ||
| 19/04/2016 | Outgoing Correspondence | Outgoing Letter | 2 | /1/5/4/0/0/0400300451/docs/300451_23_outgoingcorrespondence20160419022350912.pdf | ||
| 01/04/2016 | SPC Documents | Annex SPC | 1 | /1/5/4/0/0/0400300451/docs/300451_21_supplprotectioncertificate20200909041031454.pdf | ||
| 01/04/2016 | Incoming Correspondence Paper | Accompanying letter incoming document | 2 | /1/5/4/0/0/0400300451/docs/300451_26_incomingcorrespondencepaper20160406031240822.pdf | ||
| 23/06/2010 | SPC Documents | Certificate SPC | 1 | /1/5/4/0/0/0400300451/docs/300451_20_supplprotectioncertificate20200909040804852.pdf | ||
| 23/06/2010 | Outgoing Correspondence | Outgoing Letter | 1 | /1/5/4/0/0/0400300451/docs/300451_24_outgoingcorrespondence20100623.pdf | ||
| 25/05/2010 | Outgoing Correspondence | Outgoing Letter | 1 | /1/5/4/0/0/0400300451/docs/300451_1_outgoingcorrespondence20100525.pdf | ||
| 14/05/2010 | SPC Documents | Summary of the characteristics of the product | 35 | /1/5/4/0/0/0400300451/docs/300451_8_supplprotectioncertificate20200909035216345.pdf | ||
| 14/05/2010 | SPC Documents | Annex SPC | 1 | /1/5/4/0/0/0400300451/docs/300451_10_supplprotectioncertificate20200909035521814.pdf | ||
| 14/05/2010 | Incoming Correspondence Paper | Accompanying letter incoming document | 1 | /1/5/4/0/0/0400300451/docs/300451_11_incomingcorrespondencepaper20100514.pdf | ||
| 14/05/2010 | SPC Documents | Marketing Authorization SPC | 4 | /1/5/4/0/0/0400300451/docs/300451_12_supplprotectioncertificate20200909035806133.pdf | ||
| 14/05/2010 | Application Form | First filed application form | 2 | /1/5/4/0/0/0400300451/docs/300451_25_applicationform20100514.pdf |